Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

K(ATP) channel therapeutics at the bedside.

A Jahangir1, Andre Terzic

  • 1Division of Cardiovascular Diseases, Departmentof Medicine, Mayo Clinic College of Medicine, Guggenheim 7, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. jahangir.arshad@mayo.edu

Journal of Molecular and Cellular Cardiology
|June 15, 2005
PubMed
Summary

Potassium channel openers activate K(ATP) channels, crucial for cellular energy balance. These drugs show broad therapeutic potential for metabolic distress-related conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

REPLY: Is There an Intramyocardial "Purkinje" System in the Heart?

JACC. Clinical electrophysiology·2025
Same author

Healthspan-lifespan gap differs in magnitude and disease contribution across world regions.

Communications medicine·2025
Same author

MYL4 Identifies Intramural Anatomy of Purkinje Fibers in Human Hearts.

JACC. Clinical electrophysiology·2025
Same author

Maturation of human induced pluripotent stem cell-derived cardiomyocytes promoted by Brachyury priming.

Scientific reports·2025
Same author

Prevalence, Variants and Presentation of Anomalous Aortostial Origin of Coronary Arteries: A Registry Based Analysis of Ten Cases.

Mymensingh medical journal : MMJ·2025
Same author

Therapeutic effects of platelet-derived extracellular vesicles on viral myocarditis correlate with biomolecular content.

Frontiers in immunology·2025

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Physiology

Background:

  • Adenosine triphosphate-sensitive potassium (K(ATP)) channels are metabolic sensors regulating cellular functions.
  • These channels are vital in metabolically active tissues, influencing cardiovascular, neuronal, and hormonal systems.
  • K(ATP) channels are heteromultimers comprising a potassium pore and a sulfonylurea receptor subunit.

Purpose of the Study:

  • To review the therapeutic potential of potassium channel openers.
  • To highlight the role of K(ATP) channel activation in various physiological processes.
  • To discuss the emerging applications of these drugs in metabolic distress.

Main Methods:

  • Literature review of K(ATP) channel opener pharmacology.
  • Analysis of K(ATP) channel structure and function.

Related Experiment Videos

  • Exploration of clinical and preclinical data on therapeutic applications.

    • Main Results:

    • Potassium channel openers enhance K(ATP) channel activity by antagonizing ATP inhibition.
    • K(ATP) channel activity is critical for cardiovascular adaptation, neuronal stability, and hormonal balance.
    • Diverse therapeutic applications are identified, including myopreservation, vasodilation, and potential use in epilepsy and hair growth.

    Conclusions:

    • K(ATP) channel openers represent a promising therapeutic class for metabolic distress.
    • Ongoing research is expanding the understanding of their benefits in various diseases.
    • Despite limited current clinical experience, their unique mechanism offers broad therapeutic prospects.